Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 5 of 5 entries
View as:
Phase: N/A
Priority: Normal
Start: 05/14/21
End: 08/31/25
Due: 08/31/26
Fruquintinib Combined With mFOLFOX6/FOLFIRI in First-line Treatment for Metastatic Colorectal Cancer
Phase: N/A
Priority: Normal
Start: 07/22/21
End: 12/30/23
Due: 12/30/24
Preoperative IMRT With Concurrent High-dose Vitamin C and mFOLFOX6 in Locally Advanced Rectal Cancer
Phase: N/A
Priority: Normal
Start: 03/08/21
End: 12/31/24
Due: 12/31/25
Phase: N/A
Priority: Normal
Start: 05/20/17
End: 12/31/21
Due: 12/31/22
Phase: N/A
Priority: Normal
Start: 02/07/22
End: 12/31/24
Due: 12/31/25